Celebrating a Shared Milestone: BioDlink and Lepu Biopharma celebrated the launch of MEIYOUHENG®, the world's first EGFR-Targeting ADC, and their partnership spanning over two years. Demonstrating Robust Capabilities: Throughout the collaboration, all technology transfers and GMP manufacturing batches were achieved successfully in a single attempt, underscoring robust commercial capability and a top-tier quality system of BioDlink. The first ADC fully manufactured by a CDMO to reach the market in China, underscoring a new level of maturity for the region's biopharmaceutical
PENANG, Malaysia, Nov. 21, 2025 -- K-Beauty Expo Malaysia 2025 and K-MediTech Expo Malaysia 2025, organized by KINTEX, officially opened today at the Penang Waterfront Convention Centre (PWCC), marking a significant milestone as two of Korea's most recognised industry exhibitions debut together in Malaysia. Running concurrently from 20–22 November, the dual expos have attracted strong attendance from beauty professionals, healthcare practitioners, distributors, retailers, and visitors eager to explore Korea's latest advancements in beauty, cosmetics, medical devices, and healthcare technology
18 Years, 100+ Awards: Taiwan's R&D Prowess Shines on Global Stage TAIPEI, Nov. 21, 2025 -- Taiwan's Ministry of Economic Affairs (MOEA) announced today (21st) that six technologies it funded have won seven awards at the 2025 R&D 100 Awards, often hailed as the "Oscars of Innovation." The award-winning technologies include three from the Industrial Technology Research Institute (ITRI), one from the Taiwan Textile Research Institute (TTRI), one from the Metal Industries Research & Development Centre (MIRDC) (which also received a Special Recognition award), and one
HONG KONG, Nov. 21, 2025 -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, announced that Alma Lasers Ltd., a wholly-owned subsidiary of Sisram, has launched Universkin by Alma, the world's first AI-assisted skincare solution, in the Hong Kong market. With pioneering AI-assisted technology, Universkin by Alma enables practitioners to capture a facial image, pe
[ 메디채널 김갑성 기자 ] 300 Industry Leaders Gather to Drive Medical Innovations and Showcase Hong Kong's Strengths HONG KONG, Nov. 21, 2025 -- The International Genomic Medicine Symposium (Symposium), jointly organised by the Hong Kong Genome Institute (HKGI), Rare Diseases International (RDI), and The Lancet Commission on Rare Diseases (LCRD) opened on November 17 at the Hong Kong Science Park. This prestigious event has attracted close to 300 industry professionals, including medical practitioners, scientists, and researchers from over 20 countries and regions. Participants include distin
[ 메디채널 김갑성 기자 ] Dual certifications streamline global design transfers and regulatory compliance. TAIPEI, Nov. 21, 2025 -- IEI Integration Corp. ("IEI"), a global provider of medical and industrial computing platforms, today announced that its New Taipei City (Xizhi) and Qidu (Keelung) facilities have passed inspection by the Taiwan Food and Drug Administration (TFDA) and been awarded Quality Management System (QMS) approval (Xizhi Certificate No. QMS2376、Keelung Certificate No. QMS2377), while maintaining ISO 13485:2016 certification. As one of Taiwan's manufacturers holdi
MELBOURNE, Australia and KYOTO, Japan, Nov. 21, 2025 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the official opening of Telix Manufacturing Solutions (TMS) in Yokohama, Japan, the Company's first cyclotron facility in the Asia Pacific region (APAC). TMS Yokohama will enable Telix to provide greater access to radiopharmaceuticals for Japanese patients, initially through clinical supply of TLX250-CDx (a kidney cancer imaging candidate), with plans to supply other Telix investigational and future commercial products, i
Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring invaluable clinical development expertise to VIS-101 Program The ability to attract seasoned ophthalmology leaders highlights the compelling opportunity for VIS-101, and underscores our commitment to assembling a world-class team VIS-101, a novel bifunctional biologic targeting VEGF-A/ANG2, has the potential to become the current standard for wet AMD, DME and RVO, and is expected to be Phase-3-ready in 2026 ROCKVILLE, Md., Nov. 21, 2025 -- NovaB
The Medidata Data Experience offering will enable the National Cancer Institute Lead Protocol Organizations to expedite the development of life-saving medicines for patients SINGAPORE, Nov. 21, 2025 -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that Medidata Health Record Connect and Medidata Rave Companion, both integral components of the Medidata Data Experience, will be available to a select set of National Cancer Institute (NCI) Lead Protocol Organizations (LPO). These solutions
NEW YORK, Nov. 21, 2025 -- Observed annually on the third Thursday of November each year, Worldwide Pressure Injury Prevention Day serves as a global reminder of the urgent need to prevent pressure injuries, also known as pressure ulcers or bedsores, among vulnerable populations. Established by the National Pressure Injury Advisory Panel (NPIAP) and supported by organizations worldwide, the day aims to raise public awareness, promote evidence-based prevention strategies, and highlight the importance of early intervention for individuals at risk, including those who are bedridden, wheelchair u